Curatis Holding AG (SWX:CURN)

Market Cap	89.17M +45.8%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	5.15M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	167
Average Volume	3,435
Open	17.00
Previous Close	17.30
Day's Range	17.00 - 17.30
52-Week Range	9.14 - 19.90
Beta	n/a
RSI	58.21
Earnings Date	n/a

About Curatis Holding AG

Curatis Holding AG engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases. It offers its products in the areas of fentanyl, breakthrough pain, antiplatelet, metastatic hormone receptor-positive breast cancer, anti-arrhythmic, nasal oil, wilson’s disease, cyanide poisoning, digoxin toxicity, antihypotensive, bladder pain syndrome/intersticial cystitis, antibioticum, diagnostic ophthalmology, antiviral, ophtalmic/ antibioticum, gentamycin collage...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Roland Rutschmann
• Employees: 20
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: CURN